Le Lézard
Classified in: Health, Covid-19 virus
Subject: PER

Ariadne Labs Names Two New Members to Advisory Board


BOSTON, Jan. 12, 2021 /PRNewswire/ -- Today, Ariadne Labs welcomes two new members to its Advisory Board. Elliot Cohen and Karin Leschly will be joining the Advisory Board as trusted advisors and dedicated ambassadors to Ariadne Labs' mission to create scalable solutions that improve health care delivery at the most critical moments for people everywhere.

"We are excited to welcome Elliot and Karin to the Advisory Board as we continue to further our goal of  improving the delivery of health care in an impactful way that is efficient and equitable. They each bring distinct and exceptional perspectives to this role -- from prioritizing the underserved to transforming industries -- that Ariadne Labs will greatly benefit from," said Asaf Bitton, Executive Director, Ariadne Labs.

Elliot and Karin join the following current members of Ariadne Labs' Advisory Board:

About Ariadne Labs:

Ariadne Labs is a joint center for health systems innovation at Brigham and Women's Hospital and Harvard T.H. Chan School of Public Health. We develop simple, scalable solutions that dramatically improve the delivery of health care at critical moments to save lives and reduce suffering. Our vision is for health systems to deliver the best possible care for every patient, everywhere, every time. Visit ariadnelabs.org to learn more and covid19.ariadnelabs.org to learn about Ariadne Labs' response to COVID-19.

Media Contact: Brigid Tsai, [email protected]

SOURCE Ariadne Labs


These press releases may also interest you

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...



News published on and distributed by: